Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
47 巻, 2 号
選択された号の論文の11件中1~11を表示しています
ORIGINAL ARTICLES
  • Yoshiaki Minakata, Hisatoshi Sugiura, Toshiyuki Yamagata, Satoru Yanag ...
    2008 年 47 巻 2 号 p. 77-82
    発行日: 2008年
    公開日: 2008/01/15
    ジャーナル オープンアクセス
    Background and Objective Various extrapulmonary effects and comorbidities have been noted to contribute to the burden of chronic obstructive pulmonary disease (COPD). However, the relationship between the prevalence of COPD and non-respiratory diseases has not been well investigated. The aim of the present study was to determine whether or not COPD is different among patients already suffering from other diseases.
    Methods Spirometry was performed by patients aged ≥40 years old with non-respiratory diseases who visited primary care clinics. Four hundred eighty-one patients performed spirometry and 7 patients were excluded because of poor spirometry maneuvers, resulting in 474 patients that were eligible for the current study. In subjects showing abnormalities in their spirograms, precise diagnoses were made using a questionnaire and chest X-ray examination.
    Results Among the 474 patients, airflow limitation (FEV1/FVC<70%) was observed in 53 patients (11.2%). Forty-nine patients (10.3%) were diagnosed as COPD and 4 patients (0.8%) as bronchial asthma. Among the various diseases, the prevalence of COPD was significantly higher only in the patients with liver diseases, which was 18.8% (12 of 64 patients). The odds ratio adjusted by both the amount of smoking and age was 2.66 (95%CI 1.06-6.63, p=0.037).
    Conclusions The prevalence of COPD was different according to the type of disease, and patients with liver diseases had a higher prevalence of COPD.
  • Yoshihiro Yoshida, Shinya Ikematsu, Hisako Muramatsu, Harutoshi Sakaki ...
    2008 年 47 巻 2 号 p. 83-89
    発行日: 2008年
    公開日: 2008/01/15
    ジャーナル オープンアクセス
    Objective This study was to clarify the roles of midkine (MK) in the brain.
    Methods We determined cerebrospinal fluid MK levels in patients with neurological disorders by enzyme-linked immunoassay and immunostained autopsied brain samples in patients with meningitis.
    Results MK levels were 0.37±0.21 ng/ml in controls (n=46, mean ± S.D.), 0.67±0.19 ng/ml in patients with cerebral infarction (n=8), 1.78±1.32 ng/ml in patients with meningitis (n=25; ANOVA and post-hoc Fisher's PLSD test, p<0.0001), 0.31±0.25 ng/ml in patients with human T-lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis (n=29), and 0.42±0.17 ng/ml in patients with amyotrophic lateral sclerosis (n=8). The regression equations were Y=0.005X+0.498 (Y, CSF MK level; X, cell number) and Y=0.007X+0.326 (Y, MK level; X, protein level) for all CSF samples. Autopsy brain samples from patients with meningitis expressed MK weakly in mononuclear cells on immunohistochemical examination. Western blot and polymerase chain reaction analyses showed that leukocytes were MK positive. CSF MK levels were not high in patients with cerebral infarction but were increased in patients with meningitis. CSF MK levels were high in normal controls, compared to those of other cytokines. MK was expressed in choroid plexus of normal brain and released there.
    Conclusion Our findings suggested that MK may maintain normal adult brain as a neurotrophic factor, and that MK may be released from leucocytes in brain of patients with meningitis as an immunological mediator.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top